OrthoSensor, Inc. has received the CE Mark approval for its Verasense Knee System and is planning to soon launch its product in European markets. The Verasense Knee System is a single-use instrument system that, according to company officials, replaces the standard plastic tibial trial spacer used during knee replacement surgery. Company officials claim that the system’s proprietary software and sensor and data communications technologies empower surgeons to make evidence-based decisions regarding component placement, limb alignment and soft tissue balance to achieve balance and stability through a full range of motion. Verasense integrates seamlessly into the surgical workflow and is compatible for use with multiple leading knee implant systems.
Europe Approves Verasense Knee System
1 min read Premium comments
Secondary
“We’re pleased to have successfully achieved CE Mark for our Verasense technology. This enables us to provide OrthoSensor’s innovative technology to orthopaedic surgeons and patients in markets outside the US and creates significant growth opportunities for our business, ” said company President and CEO Jay Pierce. “It’s a vital step toward expanding our business internationally.”
OrthoSensor, Inc. develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals during surgery and post-operatively.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.